C72-34 Using Urinary Inflammatory Biomarkers to Develop Novel Phenotypes of Prematurity-Associated Lung Disease
Joint statement from GOLD/GLI regarding the use of spirometry to define airflow obstruction and diagnose COPD
ERS technical standard – Reference values for cardiopulmonary exercise testing: summary report and a call for action
What Magnitude of Change in FEV1 is Associated With Increased Odds for Asthma Exacerbation and Loss of Control?
A Review of Newborn Screening Programs for Cystic Fibrosis: Are Current Protocols Appropriate for Canada’s Diverse Population?
Translating Pulmonary Function Test Results into Practical Clinical Interpretations
Feasibility of using an automated quality control algorithm for spirometry
Reform and Remedy for Imprecision and Inequity — Ending the Race-Based Evaluation of Occupational Pulmonary Impairment
Association between e-cigarette exposure and ventilation homogeneity in young adults: a cross-sectional study
Socioeconomic burden of cystic fibrosis in Canada
Measuring the burden of cystic fibrosis: A scoping review
A race-neutral approach to the interpretation of lung function measurements
Estimating the minimum sample size for interventional and observational studies using the Lung Clearance Index as an endpoint
